Non-Fibrillar $\beta$-Amyloid Exerts Toxic Effect on Neuronal Cells

  • Kim, Hyeon-Jin (Jinis Biopharmaceuticals Co.) ;
  • Hong, Seong-Tshool (Institute of Cardiovascular Research, and Dept. of Microbiology, Chonbuk National University, Medical School)
  • Published : 2001.06.01

Abstract

Alzheimer's disease is the most common form of dementia and no cure is known so far. Extensive genetic works and in vitro experiments combined with clinical observations link amyloid $\beta$--protein (A$\beta$-) to the pathogenesis of Alzheimer's disease (AD). It was hypothesized that $A\beta$- becomes toxic when it adopts a fibrillar conformation. Recently, non-fibrillar form of $A\beta$- was observed and the potential role in the pathogenesis of AD became an interesting subject. In this study, the cytotoxicity of non-fibrillar $A\beta$- and fibrillar $A\beta$- was compared on oxidative stress, membrane damage, or nucleosome break down. Non-fibrillar $A\beta$- was not toxic in peripheral nervous system-derived cells but significantly toxic in central nervous system-derived cells while fibrillar $A\beta$- was non-selectively toxic in both cell culture. The neurotoxicity of non-fibrillar $A\beta$- was reproduced in semi-in vivo culture of mouse brain slice. In conclusion, non-fibrillar $A\beta$- could be more relevant to the selective neurodegeneration in Alzheimer's brains than fibrillar $A\beta$- and further research needs to be done for identification of the cause of AD.

Keywords

References

  1. Bouras C, Hoff PR, Giannakopoulos P, Michel J-P and Morrison JH (1994) Regopnal distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population feom a geriatric hospital. Cerb Cortex 4: 138-150 https://doi.org/10.1093/cercor/4.2.138
  2. Detoledo-Morrell L, Sullivan MP, Morrell F, Wilson RS, Bennett DA and Spencer S (1997) Alzheimer's disease: in vivo detection of differential vulnerability of brain regions. Nuerobiol Aging 18: 463-468 https://doi.org/10.1016/S0197-4580(97)00114-0
  3. Giannakopoulos P, Hof PR, Michel J-P, Guimon J and Bouras C (1997) Cerebral cortex pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373: 523-527
  4. Hardy J and Gwinn-Hardy K (1998) Genetic classification of primary neurodegenerative disease. Science 283: 1075-1079 https://doi.org/10.1126/science.282.5391.1075
  5. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB and Selkoe DJ (1999) Protofibrillar intermediates of amlyoid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19: 8876-8884
  6. Hsia AY, Masliah E, McConologue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, and Mucke L (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Ntal Acad Sci USA 96: 3228-3233 https://doi.org/10.1073/pnas.96.6.3228
  7. Howlett DR, Jennings KH, Lee DC, Clark MS, Brown F, Wetzel R, Wood SJ, Camilleri P, and Roberts GW (1995) Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4: 23-32 https://doi.org/10.1006/neur.1995.0003
  8. Jen LS, Hart AJ, Jen A, Relvas JB, Gentleman SM, Garey LJ and Patel AJ (1998) Alzheimer's peptide kills cells of retina in vivo. Nature 392: 140-141 https://doi.org/10.1038/32327
  9. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, and Klein WL (1998) Diffusible, nonfibrillar ligands derived from $A{\beta}1$-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95: 6448-6453
  10. Lue LF, Kojima N, Tomizawa K, Moriwaki A, Matsushita M, Obata K and Matsui H (1999) Soluble amyloid $\beta$ peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155: 853-862
  11. Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN and Beyreuther K (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4: 2757-2763
  12. May PC, Gitter BD, Waters DC, Simmons LK, Becker GW, Small JS and Robison PM (1992) beta-Amyloid peptude in vitro toxicity;lot-to-lot variability. Neurobiol Aging 13: 605-607 https://doi.org/10.1016/0197-4580(92)90064-5
  13. McLean CA, Cherny RA, Frase FQ, Fuller SJ, Smith MJ, Beyreuther K, Bush AI and Master CL (1999) Soluble pool of A-beta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46: 860-866 https://doi.org/10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M
  14. Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Hayte CVD, Checler F, Godaux E, Cordell B and Van Leuven F (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amlyoid precursor protein in brain. J Biol Chem 274: 6483-6492 https://doi.org/10.1074/jbc.274.10.6483
  15. Morrison JH and Hof PR (1997) Life and death of neurons in the aging brain. Science 287: 412-419 https://doi.org/10.1126/science.278.5337.412
  16. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K and McConlogue L (2000) High-level neuronal expression of Abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxictiy without plaque formation. J Neurosci 20: 4050-4058
  17. Oda T, Wals P, Osterburg HH, Johnson SA, Pasinetti GM, Morgan TE, Rozovsky I, Stine WB, Snyder SW, Holzman TF and Finch CE (1995) Clusterin (apoJ) alters the aggregation of amyloid $\beta$-peptide $(A{\beta}_1-42)$ and froms slowly sedimenting $A{\beta}$ complexes that cause oxidative stress. Exp Neurol 136: 22-31 https://doi.org/10.1006/exnr.1995.1080
  18. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, and Cotman CW (1993) Neurodegeneration induced by beta-amyloid epptides in vitro: the role of prptide assembly state. J Neurosci 13: 1676-1687
  19. Pitschke M, Prior R, Haupt M and Riesner D (1998) Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzhemer's patients by fluorescence correlation spectroscopy. Nat Med 4: 832-834 https://doi.org/10.1038/nm0798-832
  20. Pleasure SJ and Lee VM (1993) NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J Neurisci Res 35: 585-602 https://doi.org/10.1002/jnr.490350603
  21. Podlisny MB, Walsh DM, Amarante P, Ostaszewski BL, Stimson ER, Maggio JE, Teplow DB and Selkoe DJ (1998) Biochemistry 37: 3602-3611 https://doi.org/10.1021/bi972029u
  22. Roher AE, Ball MJ, Bhave SV and Wakade AR (1991) Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurins. Biochem Biophys Res Commun 174: 572-579 https://doi.org/10.1016/0006-291X(91)91455-L
  23. Roher AE, Chaney MO, Kuo Y-M, Webster SD, Stine WB, Hacerkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, Bonnell BS and Emmering MR (1996) Morphology and toxicity of $A{\beta}$-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J Biol Chem 271: 20631-20635 https://doi.org/10.1074/jbc.271.34.20631
  24. Ross RA, Spengler BA and Biedler JL (1983) Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71: 741-747
  25. Samual W, Terry RD, DeTeresa R, Butters N and Masliah E (1994) Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol 51: 772-778
  26. Scorziello A, Meucci O, Calvani M and Schettini G (1997) Acetly-L-carnitine arginine amide prevents beta 25-35-induced neurotoxicity in cerebellar granule cells. Neurochem Res 22: 257-265 https://doi.org/10.1023/A:1022430503520
  27. Selkoe DJ (1999) Translation cell biology into therapeutic advances in Alzheimer's disease. Nature 399: 23-31
  28. Stix B and Reiser G (1998) Beta-amyloid peptide 25-35 regulates basal and hormone-stimulated Ca²+ levels in cultured rat astrocytes. Neurosci Lett 243: 121-124 https://doi.org/10.1016/S0304-3940(98)00106-2
  29. Swaab DF, Lucassen PJ, van de Nes JAP, Ravid R and Salehi A (1997) Reduced neuronal activity is one of the major hallmarks of Alzheimer's disease. In: Hyman BT, Duyckaerts, Christen Y(eds),Connections, Cognition, and Alzheimer's Diseases, Springer-Verlag, Berlin, pp 83-104
  30. Wong CW, Quaranta V and Glenner GG (1985) Neuritic plaques and cerebrovascular amuloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci USA 82: 8729-8732
  31. Yanker BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-931 https://doi.org/10.1016/S0896-6273(00)80115-4
  32. Yanker BA, Dawes LR, Fisher S, Villa-Komaroff L, OsterGranite ML and Neve RL (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzhemer's disease. Science 245: 417-420 https://doi.org/10.1126/science.2474201
  33. Wernyj RP, Mattson MP and Christakos S (1999) Expression of calbindin-D28k in C6 glial cells stabilizes intracellular calcium levels and protects against apoptosis induced by calcium ionophore and amyloid beta-peptide. Mol Brain Res 64: 69-79 https://doi.org/10.1016/S0169-328X(98)00307-6